Odyssey Health ODYY
OTC ODYY
$0.01 +0.00 (+0.00%)
At close: Oct 1, 2026 · 4:00 PM EDT

Odyssey Health (ODYY) Gains from Sales and Divestitures (2023 - 2024)

Updated

Odyssey Health's Gains from Sales and Divestitures came in at $16.4 million for FY2024 (year ended Jul 31, 2024).

Analysis

Odyssey Health (ODYY) Gains from Sales and Divestitures (2023 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn
10 Odyssey Health 1.01 Mn 50,883.61 -
Historic Data

Historic Data

Download Data
DateValue
Jan 31, 2024 15.90 Mn
Oct 31, 2023 500,000.00
API Access

Odyssey Health Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=ODYY&period=max&api_key=YOUR_API_KEY